CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to NVS

Inclisiran Sodium

Phase 3
Novartis AG (NVS)

Phase 3

Development Phase

1

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q2 '27
NVSPhase 3

Inclisiran Sodium Phase 3 Est. Readout (VICTORION-2P)

Inclisiran Sodium
Q2 2027~Q
CT.gov
00%
Development History
Oct '26
NVSPhase 3

Inclisiran Sodium Phase 3 Est. Readout (V-PLAQUE)

Inclisiran Sodium
Oct 2026~
CT.gov
00%
Competitive Landscape

0 competitors in ASCVD

View Full Landscape
Drug Information

Target Indication

ASCVD

Clinical Trial

NCT03814187

Last updated: 1/31/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.